These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39181273)

  • 1. Analysis of the function, mechanism and clinical application prospect of TRPS1, a new marker for breast cancer.
    He X; Huang H; Liu Y; Li H; Ren H
    Gene; 2025 Jan; 932():148880. PubMed ID: 39181273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPS1, a sensitive marker for different histological and molecular types of breast cancer.
    Kong C; Yu B; Bi R; Xu X; Cheng Y; Yang W; Shui R
    Diagn Pathol; 2024 Sep; 19(1):121. PubMed ID: 39243111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
    Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
    Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin.
    Almási S; Kuthi L; Sejben A; Vörös A; Nagy Á; Zombori T; Cserni G
    Virchows Arch; 2023 May; 482(5):861-868. PubMed ID: 37012444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
    Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
    Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
    Ai D; Yao J; Yang F; Huo L; Chen H; Lu W; Soto LMS; Jiang M; Raso MG; Wang S; Bell D; Liu J; Wang H; Tan D; Torres-Cabala C; Gan Q; Wu Y; Albarracin C; Hung MC; Meric-Bernstam F; Wistuba II; Prieto VG; Sahin AA; Ding Q
    Mod Pathol; 2021 Apr; 34(4):710-719. PubMed ID: 33011748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
    Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
    Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPS1 is a promising marker for all subtypes of breast cancer.
    Lui JW; Tsang JY; Li J; Ko CW; Tam F; Loong TC; Tse GM
    Histopathology; 2024 Apr; 84(5):822-836. PubMed ID: 38173281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples.
    Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F
    Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
    Witwicki RM; Ekram MB; Qiu X; Janiszewska M; Shu S; Kwon M; Trinh A; Frias E; Ramadan N; Hoffman G; Yu K; Xie Y; McAllister G; McDonald R; Golji J; Schlabach M; deWeck A; Keen N; Chan HM; Ruddy D; Rejtar T; Sovath S; Silver S; Sellers WR; Jagani Z; Hogarty MD; Roberts C; Brown M; Stegmaier K; Long H; Shivdasani RA; Pellman D; Polyak K
    Cell Rep; 2018 Oct; 25(5):1255-1267.e5. PubMed ID: 30380416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
    Parkinson B; Chen W; Shen T; Parwani AV; Li Z
    Am J Surg Pathol; 2022 Mar; 46(3):415-423. PubMed ID: 35175968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Chen CJ; Hang JF; Chen YA; Lin SJ; Chiu HM; Hsu CY; Lai CR; Yang CS
    Cancer Cytopathol; 2023 Apr; 131(4):226-233. PubMed ID: 36399408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
    Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
    Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.
    Wu H; Huang Z; Huang M; Dang Y; Lu H; Qin X; Liang L; Yang L; Ma J; Chen G; Lv Z
    Cell Cycle; 2020 Nov; 19(21):2866-2885. PubMed ID: 33044891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPS1 function beyond breast: A retrospective immunohistochemical study on non-breast cytology specimens.
    Ali A; Geetha S; Wu D; Chau K; Karam P; Khutti S; Fayyaz SS; Das K; Gimenez C; Rosca OC
    Diagn Cytopathol; 2024 Sep; 52(9):499-504. PubMed ID: 38794964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
    Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
    J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.
    Su P; Hu J; Zhang H; Jia M; Li W; Jing X; Zhou G
    Diagn Pathol; 2014 Jun; 9():119. PubMed ID: 24934762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.